These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15163551)

  • 1. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
    Yeh RK; Chen J; Williams JL; Baluch M; Hundley TR; Rosenbaum RE; Kalala S; Traganos F; Benardini F; del Soldato P; Kashfi K; Rigas B
    Biochem Pharmacol; 2004 Jun; 67(12):2197-205. PubMed ID: 15163551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
    Dial EJ; Doyen JR; Lichtenberger LM
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric-oxide-donating NSAIDs as agents for cancer prevention.
    Rigas B; Kashfi K
    Trends Mol Med; 2004 Jul; 10(7):324-30. PubMed ID: 15242680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel agents for cancer prevention based on nitric oxide.
    Rigas B
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1364-8. PubMed ID: 17956352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.
    Shiff SJ; Koutsos MI; Qiao L; Rigas B
    Exp Cell Res; 1996 Jan; 222(1):179-88. PubMed ID: 8549662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
    Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
    Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets of nitric-oxide-donating aspirin in cancer.
    Kashfi K; Rigas B
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):701-4. PubMed ID: 16042578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect.
    Kashfi K; Rayyan Y; Qiao LL; Williams JL; Chen J; Del Soldato P; Traganos F; Rigas B; Ryann Y
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1273-82. PubMed ID: 12438552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez C; Praveen Rao PN; Knaus EE
    J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
    Kashfi K; Borgo S; Williams JL; Chen J; Gao J; Glekas A; Benedini F; Del Soldato P; Rigas B
    J Pharmacol Exp Ther; 2005 Mar; 312(3):978-88. PubMed ID: 15528453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel agents based on nitric oxide for the control of colon cancer.
    Kozoni V; Rosenberg T; Rigas B
    Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
    Andrews J; Djakiew D; Krygier S; Andrews P
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):277-84. PubMed ID: 12357301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
    Chattopadhyay M; Goswami S; Rodes DB; Kodela R; Velazquez CA; Boring D; Crowell JA; Kashfi K
    Cancer Lett; 2010 Dec; 298(2):204-11. PubMed ID: 20674154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of nitric oxide-donating aspirin.
    Kashfi K; Rigas B
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines.
    Lavagna C; Burgaud JL; Del Soldato P; Rampal P
    Biochem Biophys Res Commun; 2001 Jun; 284(3):808-16. PubMed ID: 11396974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.